基于真实世界喜炎平注射液治疗细菌性痢疾的临床用药特征
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R516.4

基金项目:

国家重点研发计划项目(2018YFC1707400);中国中医科学院自主选题项目(Z0650)


Clinical Medication Characteristics of Xiyanping Injection in the Treatment of Bacillary Dysentery Based on Real World Study
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:基于真实世界分析喜炎平注射液治疗细菌性痢疾的临床用药特征。方法:通过大型电子病历数据库获得157 例细菌性痢疾患者的临床资料,采用频数分析、回归分析等统计学方法开展统计分析。分析喜炎平注射液治疗细菌性痢疾用药人群的基本信息和医嘱内容,基本信息包括年龄、入院科室、出院病情;医嘱内容包括给药方式,单次、单日使用剂量,疾病诊断,联合用药。结果:使用喜炎平注射液的细菌性痢疾患者以儿科人数最多,占比76.43%。153 例患者中(4 例患者信息缺失,不列入分析),治愈116 例,占75.82%;好转34 例,占22.22%。18 岁以下患者治愈率最高,为78.72%。喜炎平注射液单次使用剂量95%置信区间为[81.08,129.25],单日药物使用剂量95%置信区间为[78.90,132.52]。随着年龄的增大,患者单次及单日使用剂量均增多。联合用药频数最高为抗生素,占比24.08%;其次为维生素,占比13.14%;中成药(主要为复方黄连素片) 占比为9.70%;中药药理类别使用频次最高的是清热剂。对喜炎平注射液联合两种药物进行关联分析法,其中最高的为含β-内酰胺酶抑制剂类的复方+青霉素,规则支持度为8.91%,置信度为90.00%。结论:临床应用喜炎平注射液治疗细菌性痢疾符合专家共识指导方案,喜炎平注射液对儿童细菌性痢疾治疗效果明显,中西医联合治疗细菌性痢疾具有较高的临床价值,中药方面多联合清热剂使用。

    Abstract:

    Abstract:Objective:To analyze the clinical medication characteristics of Xiyanping injection for bacillary dysentery based on real world study. Methods:The clinical data of 157 cases of patients with bacillary dysentery was obtained from a large electronic medical record data warehouse, and was counted and analyzed by frequency analysis, regression analysis and other statistical methods. The basic information of drug users and medical advice of Xiyanping injection for the treatment of bacillary dysentery were analyzed. The basic information included age,admission department and discharge condition;the medical advice included administration method,single and daily dosage,disease diagnosis and drug combination. Results: The number of pediatric patients with bacillary dysentery being given Xiyanping injection was the largest, accounting for 76.43%. Among the 153 cases of patients(four cases lacked information and were not included in the analysis),116 cases were cured,accounting for 75.82%;34 cases were improved,accounting for 22.22%. Patients under 18 years old had the highest cure rate, accounting for 78.72% . The 95% confidence interval for the single dosage of Xiyanping injection was [81.08,129.25],and the 95% confidence interval for the daily dosage of Xiyanping injection was[78.90,132.52]. With the increase of age, both the single dosage and the daily dosage increased. Antibiotics had the highest frequency of drug combination, accounting for 24.08% ; the next was vitamin, accounting for 13.14% ; Chinese herbal compound Huangliansu tablets accounted for 9.70% ; antipyretic agents were the most frequently used pharmacological category of Chinese medicine. Correlation analysis was conducted on Xiyanping injection combined with two drugs. The highest one is {penicillin and compounds containing β-lactamase inhibitors+penicillin,with the rule support being 8.91% and the degree of confidence being 90.00%. Conclusion:The clinical application of Xiyanping injection for bacillary dysentery is consistent with the expert consensus guidance program. Xiyanping injection has obvious curative effect in treating children with bacillary dysentery. The combination of Chinese and western medicine for bacterial dysentery has high clinical value,and antipyretic agents were often applied in Chinese medicine.

    参考文献
    相似文献
    引证文献
引用本文

赵文静,张利丹,王志飞,谢雁鸣,杨云云,范海伟,吕朗,庄严.基于真实世界喜炎平注射液治疗细菌性痢疾的临床用药特征[J].新中医,2021,53(16):81-84

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-08-23
  • 出版日期:
文章二维码